Literature DB >> 21432205

Acute caffeine effect on repeatedly measured P300.

J Pan1, T Takeshita, K Morimoto.   

Abstract

The acute effect of a single-dose of caffeine on the P300 event-related brain potential (ERP) was assessed in a study using a repeatedly presented auditory oddball button-press task. A dose (5mg/kg body-weight) of either caffeine or placebo lactose, dissolved in a cup of decaffeinated coffee, was administered double-blindly to coffee drinkers who had abstained from coffee for 24hrs, with the presentation order of the sessions counterbalanced and separated by 2-4 weeks. The caffeine-treatment condition demonstrated a smaller P300 amplitude and a shorter latency overall than the placebo treatment condition. The mean P300 amplitude value difference (caffeine minus placebo) increased with the successive trial blocks. Caffeine ingestion appears to yield a lower resource-consumption and a net increase in allocating attention resources for task performance across repeated measurements.

Entities:  

Keywords:  P300; caffeine; event-related brain potential (ERP); oddball; repeated measurement

Year:  2000        PMID: 21432205      PMCID: PMC2723445          DOI: 10.1007/BF02935910

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  29 in total

1.  Effects of stimulus repetition, duration, and rise time on startle blink and automatically elicited P300.

Authors:  L E Putnam; W T Roth
Journal:  Psychophysiology       Date:  1990-05       Impact factor: 4.016

2.  Effects of habitual caffeine use and acute ingestion: testing a biobehavioral model.

Authors:  B D Smith; J Rafferty; K Lindgren; D A Smith; A Nespor
Journal:  Physiol Behav       Date:  1992-01

3.  The effects of low doses of caffeine on human performance and mood.

Authors:  H R Lieberman; R J Wurtman; G G Emde; C Roberts; I L Coviella
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Caffeine reversal of sleep deprivation effects on alertness and mood.

Authors:  D Penetar; U McCann; D Thorne; G Kamimori; C Galinski; H Sing; M Thomas; G Belenky
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Human brain metabolic response to caffeine and the effects of tolerance.

Authors:  S R Dager; M E Layton; W Strauss; T L Richards; A Heide; S D Friedman; A A Artru; C E Hayes; S Posse
Journal:  Am J Psychiatry       Date:  1999-02       Impact factor: 18.112

6.  Effects of caffeine and diphenhydramine on auditory evoked cortical potentials.

Authors:  W J Tharion; J L Kobrick; H R Lieberman; B J Fine
Journal:  Percept Mot Skills       Date:  1993-06

7.  Withdrawal syndrome after the double-blind cessation of caffeine consumption.

Authors:  K Silverman; S M Evans; E C Strain; R R Griffiths
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

Review 8.  Stimulus functions of caffeine in humans: relation to dependence potential.

Authors:  S J Heishman; J E Henningfield
Journal:  Neurosci Biobehav Rev       Date:  1992       Impact factor: 8.989

Review 9.  Caffeine physical dependence: a review of human and laboratory animal studies.

Authors:  R R Griffiths; P P Woodson
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Caffeine intake (200 mg) in the morning affects human sleep and EEG power spectra at night.

Authors:  H P Landolt; E Werth; A A Borbély; D J Dijk
Journal:  Brain Res       Date:  1995-03-27       Impact factor: 3.252

View more
  2 in total

1.  Effects of Caffeine on Auditory- and Vestibular-Evoked Potentials in Healthy Individuals: A Double-Blind Placebo-Controlled Study.

Authors:  Elham Tavanai; Saeid Farahani; Mansoureh Adel Ghahraman; Saleheh Soleimanian; Shohreh Jalaie
Journal:  J Audiol Otol       Date:  2019-11-04

2.  Separating neural and vascular effects of caffeine using simultaneous EEG-FMRI: differential effects of caffeine on cognitive and sensorimotor brain responses.

Authors:  Ana Diukova; Jennifer Ware; Jessica E Smith; C John Evans; Kevin Murphy; Peter J Rogers; Richard G Wise
Journal:  Neuroimage       Date:  2012-04-28       Impact factor: 6.556

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.